Navigation Links
ResMed Launches Narval™ CC Mandibular Repositioning Device in the US
Date:6/13/2012

SAN DIEGO, June 13, 2012 /PRNewswire/ -- ResMed Inc. (NYSE: RMD), a leading developer, manufacturer and distributor of sleep and respiratory medical equipment, announced the US launch of Narval™ CC, its state-of-the-art mandibular repositioning device. The company unveiled the product at last week's American Academy of Dental Sleep Medicine annual meeting. Building on years of market leadership in France, its country of origin, Narval CC is an innovative, effective, world-class device that offers an alternative solution to patients for snoring and obstructive sleep apnea.

(Photo: http://photos.prnewswire.com/prnh/20120613/LA24222)

(Logo: http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO)

ResMed's introduction of Narval CC follows its acquisition of the France-based Labaratoires Narval. With the acquisition, ResMed added an additional therapy method to complement its comprehensive positive airway pressure (PAP) solutions, providing a broader offering for snoring and obstructive sleep apnea sufferers.

"Obstructive sleep apnea is a severe disease which, left untreated, can have significant long-term impacts on serious conditions including heart disease, type 2 diabetes, obesity, chronic obstructive pulmonary disease, and, as very recent research has shown, cancer," stated Michael Farrell, president, ResMed Americas.  "The gold-standard therapy for obstructive sleep apnea is PAP therapy.  However, we know that today some patients either refuse PAP treatment or fail to comply. Narval CC provides an effective alternative for those untreated patients. With the release of Narval CC, ResMed is now the only PAP company with a customized solution for noncompliant patients or patients who refuse PAP treatment, giving our customers and patients another choice in their treatment."

The Narval CC provides clinically proven treatment for snoring and OSA.(1-3) The cornerstone of the design is how it maintains the lower jaw in a forward position with a patented optimized retention of the mandible. This allows natural movement of the jaw, increasing patient comfort, and resulting in superior compliance and efficacy. Each device is custom-made to suit the complex dental anatomy of individual patients using a nimble and scalable computer-aided design and computer-aided manufacturing (CAD/CAM) process.

"Narval CC's proprietary design combined with CAD/CAM technology offers one of the lightest solutions on the market. Precision-enabled digital dentistry has arrived in the mandibular repositioning device market," said Kristie Burns, general manager, dental sleep, ResMed. "With Narval CC, we finally have a way to reach a previously untreatable patient group with a solution to help them achieve a healthy night's sleep."

About ResMed
ResMed is a global leader in the development, manufacturing and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing. The company is dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing. For more information on ResMed, visit www.resmed.com.

(1) Vecchierini M et al. Efficacy and compliance of mandibular repositioning device in obstructive sleep apnea syndrome under a patient-driven protocol of care. Sleep Med 2008;9(7):762–769
(2) Dookun R. 18 month assessment of 54 patients referred for treatment of anti-social snoring  (AHI ≤ 30/hr) with a custom Mandibular Repositioning Device (MRD). Paper presented at the World Association of Sleep Medicine & Canadian Sleep Society Congress 2011
(3) Geraads et al. First intention management of obstructive sleep apnea syndrome (OSAS) by custom-made mandibular advancement device: the medium-term results. Prospective study by the General Hospital Pneumologists College (CPHG). Rev Pneumol Clin  2010;66(5):284–292


'/>"/>
SOURCE ResMed Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ResMed Inc. Announces Plan To Initiate Dividend And Update On Chief Executive Officer Succession
2. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
3. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
4. Mylan Launches Generic Version of Zyprexa® Tablets
5. Smith & Nephew launches revolutionary open-architecture suture anchor for rotator cuff repair with greater pullout strength than competitors[i]
6. American Academy of Family Physicians Foundation Launches Cities for Life
7. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
8. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
9. Xtelligent Media Raises $800K in Funding and Launches EHRintelligence.com
10. University Hospitals Case Medical Centers Harrington Discovery Institute Launches Grant Program to Accelerate Drug Discovery and Development
11. Practice Fusion Launches API to Democratize Lab Integrations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... innovative inhaled drugs, announced today that it was added ... reconstituted its comprehensive set of U.S. and global ... is an important milestone for Pulmatrix," said Chief Executive ... awareness of our progress in developing drugs for crucial ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 24, 2016 , ... Southern Illinois University School of Dental ... Illinois State Dental Society (ISDS) Foundation’s Mission of Mercy (MOM). They will host ... Collinsville. , They expect to treat approximately 2,000 patients from Illinois, ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... a not-for-profit organization responsible for clinical transfusion research programs and for the blood ... Pathogen Reduction Evaluation and Predictive Analytical Rating Score (PREPAReS) study. , Currently ...
(Date:6/23/2016)... ... June 23, 2016 , ... SyncDog, Inc. , ... security software, is featured in the current issue of Silicon Review ... with innovative technology solutions and features them in their magazine. The magazine allows ...
(Date:6/23/2016)... ... 23, 2016 , ... Horizon Blue Cross Blue Shield of ... from the crushing burden of sky-high health care costs, Superior Court of New ... ( http://www.judiciary.state.nj.us/opinions/a2913-15a2929-15.pdf ) the court provided some analysis of the contracts between ...
(Date:6/23/2016)... ... ... A key metric of this success is the popularity of the Leafedin.org service ... areas that lack the kind of technology and networking framework that LeafedIn.org provide, where ... the marijuana industry, no matter how small or large, and more importantly no matter ...
Breaking Medicine News(10 mins):